These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15162143)

  • 1. The impact of the perception of treatment choice on satisfaction with treatment, experienced chemotherapy burden and current quality of life.
    Jansen SJ; Otten W; van de Velde CJ; Nortier JW; Stiggelbout AM
    Br J Cancer; 2004 Jul; 91(1):56-61. PubMed ID: 15162143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting patients' perceptions of choice regarding adjuvant chemotherapy for breast cancer.
    Jansen SJ; Otten W; Stiggelbout AM
    Breast Cancer Res Treat; 2006 Sep; 99(1):35-45. PubMed ID: 16541318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to cancer and leukemia group B 49907.
    Kornblith AB; Lan L; Archer L; Partridge A; Kimmick G; Hudis C; Winer E; Casey R; Bennett S; Cohen HJ; Muss HB
    J Clin Oncol; 2011 Mar; 29(8):1022-8. PubMed ID: 21300923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients' perceptions of 70-gene signature testing: commonly changing the initial inclination to undergo or forego chemotherapy and reducing decisional conflict.
    van Steenhoven JEC; den Dekker BM; Kuijer A; van Diest PJ; Nieboer P; Zuetenhorst JM; Imholz ALT; Siesling S; van Dalen T
    Breast Cancer Res Treat; 2020 Jul; 182(1):107-115. PubMed ID: 32430679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiologic study to assess patient involvement in choice of adjuvant chemotherapy for breast cancer (PROSA Study).
    Tusquets I; Espinosa Arranz E; Méndez M; Gil JM; Guallar JL; Perulero N;
    Clin Transl Oncol; 2009 Apr; 11(4):221-7. PubMed ID: 19380299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy in elderly women with breast cancer: patients' perspectives on information giving and decision making.
    Harder H; Ballinger R; Langridge C; Ring A; Fallowfield LJ
    Psychooncology; 2013 Dec; 22(12):2729-35. PubMed ID: 23813806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients' Quality of Life Over 2-Year Follow-up.
    Jeffe DB; Pérez M; Cole EF; Liu Y; Schootman M
    Ann Surg Oncol; 2016 Mar; 23(3):735-43. PubMed ID: 26511265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in axillary node-negative, estrogen receptor-negative breast cancer patients undergoing AC versus CMF chemotherapy: findings from the National Surgical Adjuvant Breast and Bowel Project B-23.
    Land SR; Kopec JA; Yothers G; Anderson S; Day R; Tang G; Ganz PA; Fisher B; Wolmark N
    Breast Cancer Res Treat; 2004 Jul; 86(2):153-64. PubMed ID: 15319567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Explaining differences in attitude toward adjuvant chemotherapy between experienced and inexperienced breast cancer patients.
    Jansen SJ; Otten W; Baas-Thijssen MC; van de Velde CJ; Nortier JW; Stiggelbout AM
    J Clin Oncol; 2005 Sep; 23(27):6623-30. PubMed ID: 16170169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
    Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
    BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term effects of extended adjuvant endocrine therapy on quality of life in breast cancer patients.
    Kool M; Fontein DB; Meershoek-Klein Kranenbarg E; Nortier JW; Rutgers EJ; Marang-van de Mheen PJ; van de Velde CJ
    Breast; 2015 Jun; 24(3):224-9. PubMed ID: 25704982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-Related Quality of Life With Trastuzumab Monotherapy Versus Trastuzumab Plus Standard Chemotherapy as Adjuvant Therapy in Older Patients With HER2-Positive Breast Cancer.
    Taira N; Sawaki M; Uemura Y; Saito T; Baba S; Kobayashi K; Kawashima H; Tsuneizumi M; Sagawa N; Bando H; Takahashi M; Yamaguchi M; Takashima T; Nakayama T; Kashiwaba M; Mizuno T; Yamamoto Y; Iwata H; Ohashi Y; Mukai H; Kawahara T;
    J Clin Oncol; 2021 Aug; 39(22):2452-2462. PubMed ID: 33835842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiety and quality of life of women who receive radiation or chemotherapy for breast cancer.
    Schreier AM; Williams SA
    Oncol Nurs Forum; 2004; 31(1):127-30. PubMed ID: 14722597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-of-life outcomes for adjuvant chemotherapy in early-stage non-small-cell lung cancer: results from a randomized trial, JBR.10.
    Bezjak A; Lee CW; Ding K; Brundage M; Winton T; Graham B; Whitehead M; Johnson DH; Livingston RB; Seymour L; Shepherd FA
    J Clin Oncol; 2008 Nov; 26(31):5052-9. PubMed ID: 18809617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-physician communication concerning participation in cancer chemotherapy trials.
    Sørensen JB; Rossel P; Holm S
    Br J Cancer; 2004 Jan; 90(2):328-32. PubMed ID: 14735172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient preferences for adjuvant chemotherapy of early breast cancer: how much benefit is needed?
    Simes RJ; Coates AS
    J Natl Cancer Inst Monogr; 2001; (30):146-52. PubMed ID: 11773309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferences and actual chemotherapy decision-making in the greater plains collaborative breast cancer study
    Berger AM; Buzalko RJ; Kupzyk KA; Gardner BJ; Djalilova DM; Otte JL
    Acta Oncol; 2017 Dec; 56(12):1690-1697. PubMed ID: 28903664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients' perception of chemotherapy side effects: Expectations, doctor-patient communication and impact on quality of life - An Italian survey.
    Lorusso D; Bria E; Costantini A; Di Maio M; Rosti G; Mancuso A
    Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 28004440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.